Interferon-gamma 1b

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
85	特発性間質性肺炎	4

85. 特発性間質性肺炎

臨床試験数 : 627 / 薬物数 : 443 - (DrugBank : 120) / 標的遺伝子数 : 99 - 標的パスウェイ数 : 212

trials per page:

Showing 1 to 4 of 4 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00052052 (ClinicalTrials.gov)	September 2002	21/1/2003	An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b(IFN-G ...	An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon Gamma-1bin Pat ...	Lung Disease;Pulmonary Fibrosis	Drug: interferon-gamma 1b	InterMune	NULL	Completed	20 Years	79 Years	Both	210	Phase 2	United States
2	NCT00052039 (ClinicalTrials.gov)	April 2002	21/1/2003	A Randomized, Double-Blind, Three-Arm, Phase 3b Study Comparing the Safety and Efficacy of Interfero ...	A Randomized, Double-Blind, Three-Arm, Phase IIIb Study Comparing the Safety and Efficacy of Interfe ...	Lung Disease;Pulmonary Fibrosis	Drug: interferon-gamma 1b;Drug: azathioprine	InterMune	NULL	Terminated	20 Years	79 Years	Both	0	Phase 3	Italy
3	NCT00047658 (ClinicalTrials.gov)	November 2001	9/10/2002	A Study of the Safety and Clinical Effects of Interferon Gamma-1bin Patients With Idiopathic Pulmona ...	A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Biology, and Clinical ...	Idiopathic Pulmonary Fibrosis	Drug: Interferon-gamma 1b	InterMune	NULL	Completed	20 Years	79 Years	Both	32	Phase 2	United States
4	NCT00047645 (ClinicalTrials.gov)	April 2000	9/10/2002	A Study of the Safety and Efficacy Interferon-Gamma 1bin Patients With Idiopathic Pulmonary Fibrosis ...	A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of the Safety and Efficacy of Subcut ...	Idiopathic Pulmonary Fibrosis	Drug: Interferon-gamma 1b	InterMune	NULL	Completed	20 Years	79 Years	Both	330	Phase 3	United States

First Previous1Next Last